Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
28.99
+0.56 (1.97%)
At close: Mar 31, 2025, 4:00 PM
28.62
-0.37 (-1.28%)
After-hours: Mar 31, 2025, 7:56 PM EDT
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Amphastar Pharmaceuticals stock have an average target of 43.5, with a low estimate of 32 and a high estimate of 55. The average target predicts an increase of 50.05% from the current stock price of 28.99.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 3 | 3 | 3 | 2 | 1 |
| Hold | 2 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $36 → $32 | Hold | Maintains | $36 → $32 | +10.38% | Mar 21, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $66 → $36 | Buy → Hold | Downgrades | $66 → $36 | +24.18% | Feb 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $55 | Buy | Initiates | $55 | +89.72% | Nov 22, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $71 → $66 | Buy | Maintains | $71 → $66 | +127.66% | Aug 8, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 8, 2024 |
Financial Forecast
Revenue This Year
751.02M
from 731.97M
Increased by 2.60%
Revenue Next Year
821.73M
from 751.02M
Increased by 9.42%
EPS This Year
3.18
from 3.06
Increased by 3.94%
EPS Next Year
3.76
from 3.18
Increased by 18.12%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 793.9M | 881.0M | 942.9M | ||
| Avg | 751.0M | 821.7M | 880.5M | ||
| Low | 711.9M | 759.3M | 811.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.5% | 17.3% | 14.7% | ||
| Avg | 2.6% | 9.4% | 7.2% | ||
| Low | -2.7% | 1.1% | -1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.68 | 4.21 | 4.73 | ||
| Avg | 3.18 | 3.76 | 4.05 | ||
| Low | 2.80 | 3.39 | 3.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.1% | 32.4% | 25.8% | ||
| Avg | 3.9% | 18.1% | 7.8% | ||
| Low | -8.4% | 6.6% | -5.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.